Search research articles
Contact Us
Filters
Showing results (271-280 of 287) with videos related to
Page
of 29
Sort By:
The Journal of Thoracic and Cardiovascular Surgery
|
December 16, 2014
Predicting recurrent mitral regurgitation after mitral valve repair for severe ischemic mitral regurgitation
Irving L Kron, Judy Hung, Jessica R Overbey, et al.
JTCVS Structural and Endovascular
|
May 14, 2026
Association of tricuspid regurgitation with clinical events and quality of life after surgery for severe ischemic mitral regurgitation
Raymond J Strobel, Benjamin P Kramer, Jessica R Overbey, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 23, 2009
Investigation of aminopyridiopyrazinones as PDE5 inhibitors: Evaluation of modifications to the central ring system
Robert O Hughes, John K Walker, Jerry W Cubbage, et al.
Journal of the American College of Cardiology
|
July 26, 2014
Management practices and major infections after cardiac surgery
Annetine C Gelijns, Alan J Moskowitz, Michael A Acker, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
December 9, 2022
Intimal hyperplasia, saphenous vein graft disease, and clinical outcomes: Insights from the CTSN VEST randomized trial
Daniel J Goldstein, Helena L Chang, Michael J Mack, et al.
Journal of Medicinal Chemistry
|
March 4, 2010
Design, synthesis, and biological evaluation of 3-[4-(2-hydroxyethyl)piperazin-1-yl]-7-(6-methoxypyridin-3-yl)-1-(2-propoxyethyl)pyrido[3,4-b]pyrazin-2(1H)-one, a potent, orally active, brain penetrant inhibitor of phosphodiesterase 5 (PDE5)
Robert O Hughes, D Joseph Rogier, E Jon Jacobsen, et al.
The New England Journal of Medicine
|
November 20, 2013
Mitral-valve repair versus replacement for severe ischemic mitral regurgitation
Michael A Acker, Michael K Parides, Louis P Perrault, et al.
The New England Journal of Medicine
|
November 19, 2014
Surgical treatment of moderate ischemic mitral regurgitation
Peter K Smith, John D Puskas, Deborah D Ascheim, et al.
JAMA
|
March 27, 2019
Intramyocardial Injection of Mesenchymal Precursor Cells and Successful Temporary Weaning From Left Ventricular Assist Device Support in Patients With Advanced Heart Failure: A Randomized Clinical Trial
Terrence M Yau, Francis D Pagani, Donna M Mancini, et al.
The New England Journal of Medicine
|
November 10, 2015
Two-Year Outcomes of Surgical Treatment of Severe Ischemic Mitral Regurgitation
Daniel Goldstein, Alan J Moskowitz, Annetine C Gelijns, et al.
Page
of 29
Search research articles
Search
Showing results (271-280 of 287) with videos related to
Sort By:
Page
of 29
The Journal of Thoracic and Cardiovascular Surgery
|
December 16, 2014
Predicting recurrent mitral regurgitation after mitral valve repair for severe ischemic mitral regurgitation
Irving L Kron, Judy Hung, Jessica R Overbey, et al.
JTCVS Structural and Endovascular
|
May 14, 2026
Association of tricuspid regurgitation with clinical events and quality of life after surgery for severe ischemic mitral regurgitation
Raymond J Strobel, Benjamin P Kramer, Jessica R Overbey, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 23, 2009
Investigation of aminopyridiopyrazinones as PDE5 inhibitors: Evaluation of modifications to the central ring system
Robert O Hughes, John K Walker, Jerry W Cubbage, et al.
Journal of the American College of Cardiology
|
July 26, 2014
Management practices and major infections after cardiac surgery
Annetine C Gelijns, Alan J Moskowitz, Michael A Acker, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
December 9, 2022
Intimal hyperplasia, saphenous vein graft disease, and clinical outcomes: Insights from the CTSN VEST randomized trial
Daniel J Goldstein, Helena L Chang, Michael J Mack, et al.
Journal of Medicinal Chemistry
|
March 4, 2010
Design, synthesis, and biological evaluation of 3-[4-(2-hydroxyethyl)piperazin-1-yl]-7-(6-methoxypyridin-3-yl)-1-(2-propoxyethyl)pyrido[3,4-b]pyrazin-2(1H)-one, a potent, orally active, brain penetrant inhibitor of phosphodiesterase 5 (PDE5)
Robert O Hughes, D Joseph Rogier, E Jon Jacobsen, et al.
The New England Journal of Medicine
|
November 20, 2013
Mitral-valve repair versus replacement for severe ischemic mitral regurgitation
Michael A Acker, Michael K Parides, Louis P Perrault, et al.
The New England Journal of Medicine
|
November 19, 2014
Surgical treatment of moderate ischemic mitral regurgitation
Peter K Smith, John D Puskas, Deborah D Ascheim, et al.
JAMA
|
March 27, 2019
Intramyocardial Injection of Mesenchymal Precursor Cells and Successful Temporary Weaning From Left Ventricular Assist Device Support in Patients With Advanced Heart Failure: A Randomized Clinical Trial
Terrence M Yau, Francis D Pagani, Donna M Mancini, et al.
The New England Journal of Medicine
|
November 10, 2015
Two-Year Outcomes of Surgical Treatment of Severe Ischemic Mitral Regurgitation
Daniel Goldstein, Alan J Moskowitz, Annetine C Gelijns, et al.
Page
of 29